Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

J Neurol. 2023 Aug;270(8):3787. doi: 10.1007/s00415-023-11784-1.
No abstract available

Publication types

  • Published Erratum